Dermatology Biotech Bambusa Raises $168.9 Million in US IPO
The company priced its initial public offering at the midpoint of its marketed range.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The story so far
1 publisher has covered this in 2 articles since 30 Oct 2026. Bloomberg.com published first, on 30 October at 00:23 UTC. The most recent article, from Bloomberg Markets, appeared on 30 October at 15:37 UTC.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Bambusa Therapeutics Inc.